awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37964916-53DFDE5E-65DC-451C-A09A-F04C9FCFBF1E
Q37964916-53DFDE5E-65DC-451C-A09A-F04C9FCFBF1E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37964916-53DFDE5E-65DC-451C-A09A-F04C9FCFBF1E
Treatment of relapsed or refractory chronic lymphocytic leukemia.
P2860
Q37964916-53DFDE5E-65DC-451C-A09A-F04C9FCFBF1E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37964916-53DFDE5E-65DC-451C-A09A-F04C9FCFBF1E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
869df2e59665d4417d948188e70f49f33e29f8fc
P2860
A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia.